| 
                                        Ocular Rosacea
 Rosacea is a dermatologic condition that affects 
								the nose, cheeks, forehead, chin, and glabella 
								(the area between the eyes and above the nose). 
								More than 50% of patients with rosacea have 
								ocular manifestations.
 
 Ocular rosacea manifestations are essentially 
								confined to the eyelids and ocular surface. 
								Problems range from minor irritation, dryness, 
								and blurry vision to potentially severe ocular 
								surface disruption and inflammatory keratitis. 
								Blepharitis and conjunctivitis are the most 
								common findings in patients with ocular rosacea
 |  |  | 
                            
                                | 
                                        Other ocular findings include 
								lid margin and conjunctival telangiectasias 
								(curly-cue blood vessels), eyelid crusting and 
								scales, punctuate epithelial erosions, corneal 
								infiltrates, corneal ulcers, and vascularization. 
								Sight-threatening disease is rare with rosacea; 
								however, keratitis can result in sterile corneal 
								ulceration and eventual perforation if not 
								treated aggressively.
                                        
 The symptoms of rosacea can be treated 
								effectively. Since rosacea is a chronic 
								condition with exacerbations and remissions, 
								long-term therapy to maintain symptomatic 
								control is required.
 
 Ocular rosacea is a syndrome of unknown cause. 
								It is commonly misdiagnosed or undiagnosed. It 
								usually has no previous family or personal 
								history. It occurs at the greatest frequency in 
								the 30- to 70- year age range, but may also be 
								found in pediatric patients. Women are affected 
								with rosacea twice as often as men. More than 
								10% of the general population exhibits 
								dermatologic characteristics of rosacea; of 
								these, up to 60% experience ocular 
								complications. Approximately 5% of patients with 
								rosacea manifest corneal disease, which may be 
								severe and can lead to blindness via corneal 
								ulceration, secondary infections, or corneal 
								opacification from vascularization.
 
 Usually, there exists a history of recurrent lid 
								problems such as “styes”, chalazia, hordeoli, 
								and chronic marginal blepharitis. Symptoms are 
								usually synonymous with the level of involvement 
								and associated complications. This is not 
								contagious!
 
 Treatment consists of daily lid hygiene. Hot 
								compresses applied to the eyelid margins can 
								help to liquefy the thick meibomian gland 
								secretions and, thus, facilitate their 
								expression. Mild, nonirritating cleaning 
								solutions, such as diluted baby shampoo or 
								commercially prepared eyelid scrubs, can be 
								applied to the eyelids to remove clogging 
								debris. Additionally, light pressure applied to 
								the eyelids can aid in gland expression. 
								Preservative free artificial tears should be 
								used liberally throughout the day and, if 
								necessary, a lubricating ointment may be used at 
								night. Antibiotics may prove to be useful. Oral 
								medications such as tetracycline, erythromycin, 
								and topical skin creams such as metronidazole 
								may be considered under doctor’s supervision. 
								Topically, steroid drops have been proven 
								helpful to reduce inflammation. Recently, newer 
								topical drop therapy using AzaSite, Blephamide, 
								Tobradex and Restasis may be used concurrently 
								to create a greater effect.
 |